Strategic COVID-19 vaccine distribution can simultaneously elevate social utility and equity

© 2022. The Author(s), under exclusive licence to Springer Nature Limited..

Balancing social utility and equity in distributing limited vaccines is a critical policy concern for protecting against the prolonged COVID-19 pandemic and future health emergencies. What is the nature of the trade-off between maximizing collective welfare and minimizing disparities between more and less privileged communities? To evaluate vaccination strategies, we propose an epidemic model that explicitly accounts for both demographic and mobility differences among communities and their associations with heterogeneous COVID-19 risks, then calibrate it with large-scale data. Using this model, we find that social utility and equity can be simultaneously improved when vaccine access is prioritized for the most disadvantaged communities, which holds even when such communities manifest considerable vaccine reluctance. Nevertheless, equity among distinct demographic features may conflict; for example, low-income neighbourhoods might have fewer elder citizens. We design two behaviour-and-demography-aware indices, community risk and societal risk, which capture the risks communities face and those they impose on society from not being vaccinated, to inform the design of comprehensive vaccine distribution strategies. Our study provides a framework for uniting utility and equity-based considerations in vaccine distribution and sheds light on how to balance multiple ethical values in complex settings for epidemic control.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:6

Enthalten in:

Nature human behaviour - 6(2022), 11 vom: 25. Nov., Seite 1503-1514

Sprache:

Englisch

Beteiligte Personen:

Chen, Lin [VerfasserIn]
Xu, Fengli [VerfasserIn]
Han, Zhenyu [VerfasserIn]
Tang, Kun [VerfasserIn]
Hui, Pan [VerfasserIn]
Evans, James [VerfasserIn]
Li, Yong [VerfasserIn]

Links:

Volltext

Themen:

COVID-19 Vaccines
Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 22.11.2022

Date Revised 15.12.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1038/s41562-022-01429-0

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM345270835